Cartesian Therapeutics Cash from Operations (TTM) Insights

Cartesian Therapeutics Inc (RNAC)

25.46 +0.86 (+3.50%) USD | NASDAQ | May 22, 16:00

24.19 -1.27 (-4.99%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
March 31, 2024	-58.31M
December 31, 2023	-51.16M
September 30, 2023	-39.72M
June 30, 2023	-26.16M
March 31, 2023	-28.53M
December 31, 2022	-31.63M
September 30, 2022	-51.24M
June 30, 2022	-66.34M
March 31, 2022	-60.11M
December 31, 2021	-60.38M
September 30, 2021	-36.17M
June 30, 2021	40.21M
March 31, 2021	34.45M
December 31, 2020	34.88M
September 30, 2020	29.26M
June 30, 2020	-47.50M
March 31, 2020	-42.89M

Date	Value
December 31, 2019	-51.44M
September 30, 2019	-51.31M
June 30, 2019	-56.22M
March 31, 2019	-65.99M
December 31, 2018	-59.16M
September 30, 2018	-59.07M
June 30, 2018	-58.48M
March 31, 2018	-50.12M
December 31, 2017	-52.03M
September 30, 2017	-37.88M
June 30, 2017	-27.91M
March 31, 2017	-24.91M
December 31, 2016	-19.76M
September 30, 2016	-28.88M
June 30, 2016	-29.02M
March 31, 2016	-27.73M
December 31, 2015	-22.46M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-66.34M

Minimum

Jun 2022

40.21M

Maximum

Jun 2021

-31.02M

Average

-45.20M

Median

Cash from Operations (TTM) Benchmarks